$30,000 of MAXIMUS lobbying was just disclosed, from Q3 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Education to medical disability exams"
You can find more data on corporate lobbying on Quiver Quantitative.
MMS Insider Trading Activity
MMS insiders have traded $MMS stock on the open market 6 times in the past 6 months. Of those trades, 5 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $MMS stock by insiders over the last 6 months:
- GAYATHRI RAJAN has made 2 purchases buying 124 shares for an estimated $9,609 and 1 sale selling 7,913 shares for an estimated $572,777.
- RAYMOND B RUDDY purchased 1,435 shares for an estimated $99,962
- MICHAEL J. WARREN has made 2 purchases buying 31 shares for an estimated $2,466 and 0 sales.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
MMS Hedge Fund Activity
We have seen 195 institutional investors add shares of MMS stock to their portfolio, and 163 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- JANUS HENDERSON GROUP PLC removed 415,501 shares (-43.9%) from their portfolio in Q2 2025, for an estimated $29,168,170
- POINT72 ASSET MANAGEMENT, L.P. added 403,309 shares (+112.7%) to their portfolio in Q2 2025, for an estimated $28,312,291
- MAN GROUP PLC removed 395,345 shares (-95.9%) from their portfolio in Q2 2025, for an estimated $27,753,219
- MACKENZIE FINANCIAL CORP removed 284,973 shares (-10.2%) from their portfolio in Q2 2025, for an estimated $20,005,104
- NORGES BANK removed 274,902 shares (-28.7%) from their portfolio in Q2 2025, for an estimated $19,298,120
- BOSTON PARTNERS added 247,782 shares (+80.5%) to their portfolio in Q2 2025, for an estimated $17,394,296
- RIVER ROAD ASSET MANAGEMENT, LLC added 244,687 shares (+inf%) to their portfolio in Q2 2025, for an estimated $17,177,027
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
